CareDx announces completion of enrollment in multicenter kidney transplant study
CareDx announced that the DART study has reached its enrollment goal. The Circulating Donor-Derived Cell-Free DNA in blood for diagnosing Acute Rejection in Kidney Transplant Recipients (DART) study is a prospective, multicenter, observational study of kidney transplant recipients. May 27, 2016